Emerging Trends in Diabetes Care: Key Updates from the 2026 ADA Standards of Care in Diabetes

Share This Event

*Registration payment includes Credit Cards and Interfund Transfers ONLY.

Target Audience

Pharmacists, Pharmacy Technicians, Nurses, Nurse Practioners

Description

This knowledge-based CPE activity provides an in-depth review of the 2026 ADA Standards of Care in Diabetes, highlighting key updates that impact clinical practice. Participants will explore changes in treatment and monitoring recommendations, examine emerging therapeutic classes and technologies, and evaluate comparative efficacy and safety data for available options. Through case-based discussions, pharmacists and pharmacy technicians will learn how to apply a patient-centered approach to integrate guideline updates into real-world scenarios, ensuring optimal diabetes management and improved patient outcomes.

Live Webinar Information
This webinar will be broadcast with Zoom. Instructions to join the webinar will be emailed prior to the event. Please go to our live webinar requirements page for more information and to test the computer/device and network prior to the event.


Continuing Education Credit For Pharmacists:
The University Of North Carolina Eshelman School Of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The program ACPE #0046-9999-26-034-L01-P/T (Pharmacist and Pharmacy Tech) provides 2.0 contact hours of continuing pharmacy education credit. To receive CE credit, you must complete the CE attendance form and the evaluation of the program. Statement of credit can be viewed and printed in CPE Monitor. Statements of CE Credit will be processed in approximately 2 to 3 weeks. **No partial credit will be available**

Objectives

• PHARMACIST: Describe changes to treatment and monitoring recommendations in the 2026 ADA Standards of Care in Diabetes.
• PHARMACIST: Discuss the role of emerging therapeutic classes and technologies in shaping diabetes management.
• PHARMACIST: Compare and contrast available treatment options, recognizing efficacy and safety data.
• PHARMACIST: Apply a patient-centered approach to incorporate guideline updates into clinical scenarios.
• Pharmacy Technician: Describe changes to treatment and monitoring recommendations in the 2026 ADA Standards of Care in Diabetes.
• Pharmacy Technician: List two new treatment and/or monitoring options available for type 2 diabetes.
• Pharmacy Technician: Discuss major adverse events or barriers associated with new treatment and monitoring options for type 2 diabetes.
• Pharmacy Technician: Identify potentially beneficial agents for the treatment of type 2 diabetes based on patient preferences and characteristics.

Sessions